The MARVIN Chatbots to Provide Information for Different Health Conditions
A Master Research Protocol to Adapt and Evaluate an Artificial Intelligence Based Conversational Agent to Provide Information for Different Health Conditions: the MARVIN Chatbots
McGill University Health Centre/Research Institute of the McGill University Health Centre
400 participants
Mar 1, 2024
INTERVENTIONAL
Conditions
Summary
This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Chatbot on Meta (Facebook) Messenger for HIV Patients
Chatbot on Meta (Facebook) Messenger for community pharmacists
Chatbot on Meta (Facebook) Messenger for breast cancer patients
CHatbot to Assist the Management of Pediatric patients with infectious conditions (CHAMP)
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05789901